Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2022 Oct 26;30:324. doi: 10.1016/j.omtn.2022.10.007

Retraction Notice to: Long Noncoding RNA OIP5-AS1 Promotes the Progression of Liver Hepatocellular Carcinoma via Regulating the hsa-miR-26a-3p/EPHA2 Axis

Yu-Shui Ma, Kai-Jian Chu, Chang-Chun Ling, Ting-Miao Wu, Xu-Chao Zhu, Ji-Bin Liu, Fei Yu, Zhi-Zhen Li, Jing-Han Wang, Qing-Xiang Gao, Bin Yi, Hui-Min Wang, Li-Peng Gu, Liu Li, Lin-Lin Tian, Yi Shi, Xiao-Qing Jiang, Da Fu , Xiong-Wen Zhang ∗∗
PMCID: PMC9619137  PMID: 36381584

Main text

(Molecular Therapy: Nucleic Acids 21, 229–241; September 2020)

This article has been retracted at the request of the editor-in-chief.

Corresponding author D.F. reached out to the journal to request a correction because "Fig. 2F was displayed mistakenly." An investigation by the editorial office revealed evidence for image duplication in identical or altered fashion in Figures 2F and 4D as well evidence of image duplication in identical or altered fashion between Figures 2F and 4D in the this article and Figure 5H in “MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma” (Deng et al., 2016, Sci. Rep. 6, 26679, https://doi.org/10.1038/srep26679) and Figure 3B in “Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma” (Zhang et al., 2019, Cell Death Discov., 5, 84, https://doi.org/10.1038/s41420-019-0164-8). This reuse (and in part misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to retract.

Contributor Information

Da Fu, Email: fu800da900@126.com.

Xiong-Wen Zhang, Email: xwzhang@sat.ecnu.edu.cn.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES